Colony Group’s GSK GSK Stock Holding History

Colony Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,588	Closed	-$372K	–	820
2022 Q4	$372K	Buy	+10,588	New	+$372K	0.01%	680
2022 Q3	–	Sell	-7,590	Closed	-$413K	–	800
2022 Q2	$413K	Buy	7,590 +3,733	+97%	+$203K	0.01%	637
2022 Q1	$210K	Sell	3,857 -3,733	-49%	-$203K	﹤0.01%	804
2021 Q4	$418K	Buy	+7,590	New	+$418K	0.01%	625
2021 Q2	–	Sell	-4,494	Closed	-$200K	–	778
2021 Q1	$200K	Sell	4,494 -3,795	-46%	-$169K	﹤0.01%	735
2020 Q4	$381K	Buy	8,289 +3,919	+90%	+$180K	0.01%	555
2020 Q3	$206K	Sell	4,370 -372	-8%	-$17.5K	0.01%	681
2020 Q2	$242K	Sell	4,742 -162	-3%	-$8.27K	0.01%	601
2020 Q1	$232K	Sell	4,904 -279	-5%	-$13.2K	0.01%	606
2019 Q4	$304K	Sell	5,183 -266	-5%	-$15.6K	0.01%	629
2019 Q3	$291K	Sell	5,449 -1,283	-19%	-$68.5K	0.01%	587
2019 Q2	$337K	Sell	6,732 -1,165	-15%	-$58.3K	0.01%	573
2019 Q1	$413K	Buy	7,897 +3,510	+80%	+$184K	0.02%	439
2018 Q4	$210K	Buy	4,387 +24	+0.6%	+$1.15K	0.01%	464
2018 Q3	$219K	Buy	4,363 +122	+3%	+$6.12K	0.01%	472
2018 Q2	$214K	Sell	4,241 -5	-0.1%	-$252	0.01%	467
2018 Q1	$207K	Buy	+4,246	New	+$207K	0.01%	471
2017 Q3	–	Sell	-57,839	Closed	-$3.12M	–	455
2017 Q2	$3.12M	Buy	57,839 +3,133	+6%	+$169K	0.22%	94
2017 Q1	$2.88M	Buy	+54,706	New	+$2.88M	0.27%	79
2016 Q1	–	Sell	-57,998	Closed	-$2.93M	–	401
2015 Q4	$2.93M	Sell	57,998 -1,040	-2%	-$52.5K	0.27%	82
2015 Q3	$2.84M	Buy	59,038 +80	+0.1%	+$3.85K	0.33%	69
2015 Q2	$3.07M	Buy	58,958 +57,532	+4,035%	+$3M	0.32%	69
2015 Q1	$82K	Sell	1,426 -60,224	-98%	-$3.46M	0.01%	377
2014 Q4	$3.29M	Buy	61,650 +2,568	+4%	+$137K	0.34%	70
2014 Q3	$3.4M	Buy	59,082 +57,532	+3,712%	+$3.31M	0.38%	58
2014 Q2	$104K	Sell	1,550 -14,656	-90%	-$983K	0.01%	266
2014 Q1	$1.08M	Buy	16,206 +84	+0.5%	+$5.61K	0.15%	115
2013 Q4	$1.08M	Buy	+16,122	New	+$1.08M	0.15%	115